Insta
SII's Covishield vaccine (Pic Via Twitter)
In a big boost for India's fight against the Covid-19 pandemic, the Drug Controller General of India (DCGI) has granted emergency use approval to Hyderabad-based Bharat Biotech's Covaxin and Pune-based Serum Institute of India's Covishield.
The approval comes after the Subject Expert Committee (SEC) of the Central Drug Standard Control Organisation (CDSCO), India's drug regulator, on Saturday (2 January) recommended emergency use approval for the Covid-19 vaccine candidates from both the pharma firms.
The SEC consists of domain knowledge experts from the fields of pulmonology, immunology, microbiology, pharmacology, paediatrics, internal medicine, etc.
After detailed deliberations on safety and immunogenicity data, Subject Expert Committee recommended for the grant of permission to Serum Institute's Covishield Covid-19 vaccine for restricted use in emergency situation subject to certain regulatory conditions, the Health Ministry said in a statement.
The SEC also reviewed the data on safety and immunogenicity of Bharat Biotech's Covid-19 vaccine and recommended for "grant of permission for restricted use in emergency situation in public interest as an abundant precaution, in clinical trial mode, to have more options for vaccinations, especially in case of infection by mutant strains", the ministry said.
"After adequate examination, CDSCO has decided to accept the recommendations of the Expert Committee and accordingly, vaccines of Serum and Bharat Biotech are being approved for restricted use in emergency situation," it said.
Both the vaccines have to be administered in two doses, the ministry said.
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.
Latest